EW
46
3
BRK.B
45
2
AMG
57
2
NWS
60
-4
DAL
79
-4
VRSN
58
2
ALL
51
3
WYNN
38
-3
AEE
64
3
INTU
56
3
DOV
69
2
CPB
40
3
XOM
40
-7
BBY
42
2
VTR
55
8
FOXA
53
3
WDC
63
13
NVDA
54
2
ADT
50
2
RL
80
2
EW
46
3
BRK.B
45
2
AMG
57
2
NWS
60
-4
DAL
79
-4
VRSN
58
2
ALL
51
3
WYNN
38
-3
AEE
64
3
INTU
56
3
DOV
69
2
CPB
40
3
XOM
40
-7
BBY
42
2
VTR
55
8
FOXA
53
3
WDC
63
13
NVDA
54
2
ADT
50
2
RL
80
2
Financhill
Back

SPDR® MSCI Emerging Mkts StratcFacts ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
41

QEMM
SPDR® MSCI Emerging Mkts StratcFacts ETF

Last Price:
59.60
Seasonality Move:
2.06%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.86
Seasonality Move:
14.88%
Sell
41
SPDR® MSCI Emerging Mkts StratcFacts ETF (QEMM) is a Sell

Is SPDR® MSCI Emerging Mkts StratcFacts ETF a Buy, Sell or Hold?

  • The current SPDR® MSCI Emerging Mkts StratcFacts ETF [QEMM] share price is $59.48. The Score for QEMM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • QEMM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QEMM Stock Price Chart

What is SPDR® MSCI Emerging Mkts StratcFacts ETF's stock price today?

  • The SPDR® MSCI Emerging Mkts StratcFacts ETF share price today is $59.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QEMM is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

QEMM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 40.18 Sell
Chaikin Money Flow: -850 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.54 - 61.26) Sell
Bollinger Bands (100): (58.75 - 62.03) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

QEMM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.58 Sell
20-day SMA: 60.15 Sell
50-day SMA: 61.46 Sell
200-day SMA: 59.25 Buy
8-day EMA: 59.67 Sell
20-day EMA: 60.14 Sell
50-day EMA: 60.62 Sell
200-day EMA: 59.33 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

SPDR® MSCI Emerging Mkts StratcFacts ETF Earnings Growth & QEMM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

SPDR® MSCI Emerging Mkts StratcFacts ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):